Completed PHASE2 INTERVENTIONAL 2-arm NCT03210558

Study of Testosterone and Athlete Response (STAR)

Effects of Moderately Increased Testosterone Concentration on Physical Performance and Behaviour in Healthy Women - a Double-blind, Randomized, Placebo-controlled Study

Sponsor: Karolinska University Hospital

Conditions Athletic Performance Testosterone Women's Health: Female Athlete/Female Athlete Triad

Interventions Placebo cream Testosterone cream 1% (Andro-Feme® )

Updated 8 times since 2017 Last updated: Oct 9, 2022 Started: May 26, 2017 Primary completion: Jun 20, 2018 Completion: Jun 20, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Athletic Performance and Testosterone and is currently completed. Karolinska University Hospital leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Nov 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Nov 2022 [monthly]

Completed PHASE2
Sep 2019 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Sep 2018 — Sep 2019 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jun 2018 — Sep 2018 [monthly]

Recruiting PHASE2
Aug 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karolinska University Hospital
The Swedish School of Sport and Health Sciences

Data source: Karolinska University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stockholm, Sweden